19 Sep Built to Sell: Selling iLab for 6× ARR, Choosing Strategic Over PE, and Life After an Eight-Figure Exit
In 2006, Tad Fallows and two friends spotted a problem inside Harvard’s cancer labs: researchers were spending more time managing freezers, fruit flies, and mice than actually doing research. They built iLab, a SaaS tool for universities and hospitals, bootstrapped it to high–7-figure ARR, and eventually sold to Agilent Technologies for roughly six times revenue.
